Concepedia

Publication | Closed Access

Reactivation of hepatitis and lamivudine therapy in 11 HBsAg‐positive renal allograft recipients: a single centre experience

16

Citations

22

References

2006

Year

Abstract

For HBsAg (+) renal allograft recipients, careful monitoring of HBV-DNA levels and timely administration of lamivudine could prevent hepatic damage caused by reactivation of hepatitis.

References

YearCitations

1999

1.2K

2000

695

2001

628

2003

539

2001

418

1998

367

2000

350

2000

202

1996

178

2002

161

Page 1